2024 UPDATE: the Brazilian Diabetes Society position on the management of metabolic dysfunction-associated steatotic liver disease (MASLD) in people with prediabetes or type 2 diabetes.
Journal Information
Full Title: Diabetol Metab Syndr
Abbreviation: Diabetol Metab Syndr
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Endocrinology & Metabolism
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declarations Ethics approval and consent to participateNot applicable. Consent for publicationAll the authors approved this study for publication. Competing interestsAFG-M received grants from AstraZeneca and Novo Nordisk. CMV received grants from Amgen, AstraZeneca, and Novo Nordisk. WSSJ received grants from Abbott, AstraZeneca, Libbs, Mantecorp, Novo Nordisk, Servier, and Torrent. JMA-N received grants from AstraZeneca, Bayer, Biolab, Gilead, Mantecorp, and Novo Nordisk. MCB received grants from Aché, AstraZeneca, Bayer, Boehringer-Inghelheim, Eli Lilly, and Novo Nordisk. Competing interests AFG-M received grants from AstraZeneca and Novo Nordisk. CMV received grants from Amgen, AstraZeneca, and Novo Nordisk. WSSJ received grants from Abbott, AstraZeneca, Libbs, Mantecorp, Novo Nordisk, Servier, and Torrent. JMA-N received grants from AstraZeneca, Bayer, Biolab, Gilead, Mantecorp, and Novo Nordisk. MCB received grants from Aché, AstraZeneca, Bayer, Boehringer-Inghelheim, Eli Lilly, and Novo Nordisk."
"Funding Sociedade Brasileira de Diabetes supported publication costs."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025